164 related articles for article (PubMed ID: 10340923)
1. Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population.
Tateishi T; Chida M; Ariyoshi N; Mizorogi Y; Kamataki T; Kobayashi S
Clin Pharmacol Ther; 1999 May; 65(5):570-5. PubMed ID: 10340923
[TBL] [Abstract][Full Text] [Related]
2. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.
Kubota T; Yamaura Y; Ohkawa N; Hara H; Chiba K
Br J Clin Pharmacol; 2000 Jul; 50(1):31-4. PubMed ID: 10886115
[TBL] [Abstract][Full Text] [Related]
3. Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.
Kiyotani K; Shimizu M; Kumai T; Kamataki T; Kobayashi S; Yamazaki H
Eur J Clin Pharmacol; 2010 Oct; 66(10):1065-8. PubMed ID: 20700584
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activity of dextromethorphan O-demethylation in healthy Japanese volunteers carrying duplicated CYP2D6 genes: duplicated allele of CYP2D6*10 does not increase CYP2D6 metabolic activity.
Ishiguro A; Kubota T; Ishikawa H; Iga T
Clin Chim Acta; 2004 Jun; 344(1-2):201-4. PubMed ID: 15149890
[TBL] [Abstract][Full Text] [Related]
5. Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizers.
Evans WE; Relling MV
Pharmacogenetics; 1991 Dec; 1(3):143-8. PubMed ID: 1688245
[TBL] [Abstract][Full Text] [Related]
6. Prediction of phenotype for dextromethorphan O-demethylation by using polymerase chain reaction in healthy volunteers.
Zimmermann T; Schlenk R; Pfaff G; Lach P; Wildfeuer A
Arzneimittelforschung; 1995 Jan; 45(1):41-3. PubMed ID: 7893267
[TBL] [Abstract][Full Text] [Related]
7. Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.
Cai WM; Chen B; Zhang WX
Clin Pharmacol Ther; 2007 Jan; 81(1):95-8. PubMed ID: 17186005
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of genetic polymorphism of cytochrome P4502D6 with dextromethorphan oxidative metabolism in Chinese].
Cai W; Chen B; Tao X; Ling S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):181-4. PubMed ID: 10837520
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
Sachse C; Brockmöller J; Bauer S; Roots I
Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
[TBL] [Abstract][Full Text] [Related]
10. Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population.
Roh HK; Dahl ML; Johansson I; Ingelman-Sundberg M; Cha YN; Bertilsson L
Pharmacogenetics; 1996 Oct; 6(5):441-7. PubMed ID: 8946476
[TBL] [Abstract][Full Text] [Related]
11. CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.
Panserat S; Sica L; Gérard N; Mathieu H; Jacqz-Aigrain E; Krishnamoorthy R
Br J Clin Pharmacol; 1999 Jan; 47(1):121-4. PubMed ID: 10073750
[TBL] [Abstract][Full Text] [Related]
12. Frequency distribution of dextromethorphan O-demethylation in a Greek population.
Kimiskidis VK; Niopas I; Firinidis PD; Kanaze FI; Gabrieli C; Kazis D; Papagiannopoulos S; Kazis A
Int J Clin Pharmacol Ther; 2005 Mar; 43(3):150-3. PubMed ID: 15792399
[TBL] [Abstract][Full Text] [Related]
13. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.
Gaedigk A; Bradford LD; Marcucci KA; Leeder JS
Clin Pharmacol Ther; 2002 Jul; 72(1):76-89. PubMed ID: 12152006
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 genotype and phenotype relationship in South Indians.
Naveen AT; Prasanna T; Farzana BL; Rajan S; Adithan C
J Postgrad Med; 2006; 52(4):253-6. PubMed ID: 17102541
[TBL] [Abstract][Full Text] [Related]
15. Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.
Hou ZY; Chen CP; Yang WC; Lai MD; Buchert ET; Chung HM; Pickle LW; Woosley RL
Clin Pharmacol Ther; 1996 Apr; 59(4):411-7. PubMed ID: 8612385
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
Funck-Brentano C; Thomas G; Jacqz-Aigrain E; Poirier JM; Simon T; Béréziat G; Jaillon P
J Pharmacol Exp Ther; 1992 Nov; 263(2):780-6. PubMed ID: 1432700
[TBL] [Abstract][Full Text] [Related]
17. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.
Madeira M; Levine M; Chang TK; Mirfazaelian A; Bellward GD
Drug Metab Dispos; 2004 Apr; 32(4):460-7. PubMed ID: 16680870
[TBL] [Abstract][Full Text] [Related]
18. Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.
Bathum L; Skjelbo E; Mutabingwa TK; Madsen H; Hørder M; Brøsen K
Br J Clin Pharmacol; 1999 Sep; 48(3):395-401. PubMed ID: 10510152
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans.
Lee SJ; Lee SS; Jung HJ; Kim HS; Park SJ; Yeo CW; Shin JG
Drug Metab Dispos; 2009 Jul; 37(7):1464-70. PubMed ID: 19364831
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians.
Droll K; Bruce-Mensah K; Otton SV; Gaedigk A; Sellers EM; Tyndale RF
Pharmacogenetics; 1998 Aug; 8(4):325-33. PubMed ID: 9731719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
